Telotristat: Side Effects, Uses & Monitoring
Facts extracted from current FDA product labeling for Telotristat. Educational only — not medical advice.
Labeled uses
Xermelo is indicated for the treatment of carcinoid syndrome diarrhea in combination with somatostatin analog (SSA) therapy in adults inadequately controlled by SSA therapy.
Source: FDA labeling via NIH DailyMed (set f11c21f8…). Not affiliated with FDA or NIH.
Medical disclaimer: Always consult a qualified healthcare professional about any medication.